Swine flu jabs ready for testing

US pharmaceutical firm Baxter International has announced completion of the first commercial batches of a human swine flu vaccine.

The medication, called Celvapan A/H1N1, was completed in late July. It must now undergo clinical trials which are scheduled to begin later this month.